Adenis A, Kulkarni AS, Girotto GC, de la Fouchardiere C, et al. Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181. J Clin Oncol 2021 Nov 3:JCO2100601. doi: 10.1200/JCO.21.00601.
PMID: 34730989